Moors & Cabot’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,646
Closed -$204K 930
2021
Q4
$204K Buy
+1,646
New +$197K 0.01% 773
2017
Q1
Sell
-4,146
Closed -$237K 538
2016
Q4
$237K Sell
4,146
-282
-6% -$16.3K 0.04% 437
2016
Q3
$269K Sell
4,428
-1,195
-21% -$72.7K 0.05% 409
2016
Q2
$329K Sell
5,623
-500
-8% -$29K 0.06% 351
2016
Q1
$339K Sell
6,123
-5,432
-47% -$294K 0.06% 321
2015
Q4
$698K Sell
11,555
-472
-4% -$28.2K 0.13% 204
2015
Q3
$698K Buy
12,027
+1,059
+10% +$70.3K 0.13% 201
2015
Q2
$758K Buy
10,968
+306
+3% +$20.7K 0.12% 200
2015
Q1
$714K Sell
10,662
-1,136
-10% -$72.4K 0.12% 202
2014
Q4
$709K Sell
11,798
-579
-5% -$33.8K 0.12% 201
2014
Q3
$687K Sell
12,377
-625
-5% -$34.3K 0.12% 196
2014
Q2
$693K Buy
13,002
+5,200
+67% +$264K 0.12% 200
2014
Q1
$397K Buy
+7,802
New +$397K 0.1% 222

Other funds holding FXH

Moors & Cabot's FXH Position: Q1 2022 in Review

Moors & Cabot sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q1 2022, closing a stake of 1,646 shares — an estimated $204K sold.

Moors & Cabot first reported a position in FXH in Q1 2014 and held it in 13 quarters. The position peaked at $758K in Q2 2015. 231 funds tracked by Wall St. Rank hold FXH as of Q1 2022.

  • Moors & Cabot reported no remaining First Trust Health Care AlphaDEX Fund position as of Q1 2022 after selling out during the quarter.
  • Moors & Cabot sold 1,646 First Trust Health Care AlphaDEX Fund shares in Q1 2022, an estimated $204K.
  • Moors & Cabot first reported a position in First Trust Health Care AlphaDEX Fund in Q1 2014 and held it in 13 quarters.
  • Moors & Cabot's First Trust Health Care AlphaDEX Fund position peaked at $758K in Q2 2015.
  • 231 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q1 2022.

Based on Moors & Cabot's 13F filing for Q1 2022, filed 13 May 2022.